[go: up one dir, main page]

BG103947A - Derivatives of 9-oxymerythromycin - Google Patents

Derivatives of 9-oxymerythromycin

Info

Publication number
BG103947A
BG103947A BG103947A BG10394799A BG103947A BG 103947 A BG103947 A BG 103947A BG 103947 A BG103947 A BG 103947A BG 10394799 A BG10394799 A BG 10394799A BG 103947 A BG103947 A BG 103947A
Authority
BG
Bulgaria
Prior art keywords
oxymerythromycin
derivatives
compounds
methods
relates
Prior art date
Application number
BG103947A
Other languages
Bulgarian (bg)
English (en)
Inventor
Yong- Jin WU
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of BG103947A publication Critical patent/BG103947A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BG103947A 1997-06-11 1999-12-03 Derivatives of 9-oxymerythromycin BG103947A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4934997P 1997-06-11 1997-06-11
PCT/IB1998/000741 WO1998056800A1 (en) 1997-06-11 1998-05-15 9-oxime erythromycin derivatives

Publications (1)

Publication Number Publication Date
BG103947A true BG103947A (en) 2000-07-31

Family

ID=21959341

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103947A BG103947A (en) 1997-06-11 1999-12-03 Derivatives of 9-oxymerythromycin

Country Status (31)

Country Link
EP (1) EP0988308A1 (xx)
JP (1) JP2000513026A (xx)
KR (1) KR20010013660A (xx)
CN (1) CN1259135A (xx)
AP (1) AP9801253A0 (xx)
AR (1) AR012244A1 (xx)
AU (1) AU7226798A (xx)
BG (1) BG103947A (xx)
BR (1) BR9810021A (xx)
CA (1) CA2293335A1 (xx)
CO (1) CO4940506A1 (xx)
CZ (1) CZ9904388A3 (xx)
EA (1) EA199901016A1 (xx)
GT (1) GT199800074A (xx)
HN (1) HN1998000073A (xx)
HR (1) HRP980316A2 (xx)
HU (1) HUP0002252A3 (xx)
ID (1) ID24529A (xx)
IL (1) IL132767A0 (xx)
IS (1) IS5251A (xx)
MA (1) MA26505A1 (xx)
NO (1) NO996108L (xx)
OA (1) OA11225A (xx)
PA (1) PA8451801A1 (xx)
PE (1) PE79899A1 (xx)
PL (1) PL337606A1 (xx)
TN (1) TNSN98083A1 (xx)
TR (1) TR199902995T2 (xx)
TW (1) TW448174B (xx)
WO (1) WO1998056800A1 (xx)
ZA (1) ZA985018B (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000159A (es) * 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
ES2243066T3 (es) 1998-09-22 2005-11-16 Pfizer Products Inc. Antibioticos de carbamato y carbazato cetolida.
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
US6258785B1 (en) 1998-12-02 2001-07-10 Pfizer Inc. Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
US6284732B1 (en) * 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
KR20020007374A (ko) * 1999-04-16 2002-01-26 추후제출 매크롤라이드 항감염제
IL145739A0 (en) 1999-05-24 2002-07-25 Pfizer Prod Inc 13-methyl-erythromycin derivatives
ES2208334T3 (es) * 1999-06-07 2004-06-16 Abbott Laboratories Derivados cetolida de 6-0 carbamato.
ID27331A (id) * 1999-09-29 2001-03-29 Pfizer Prod Inc Pembuatan antibiotik-antibiotik ketolida karbamat
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
EP1439186A3 (en) * 1999-12-29 2004-11-03 Pfizer Products Inc. Intermediates for novel antibacterial and prokinetic macrolides
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
US6403776B1 (en) 2000-07-05 2002-06-11 Pfizer Inc. Synthesis of carbamate ketolide antibiotics
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
EP3738591A3 (en) 2003-03-10 2021-03-24 Merck Sharp & Dohme Corp. Novel antibacterial agents
US8202843B2 (en) 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
US9072759B2 (en) 2008-10-24 2015-07-07 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
CN102146085B (zh) * 2010-02-09 2014-03-26 北京理工大学 一种9-肟醚酮内酯衍生物、制备方法及其药物组合物
ES2564097T3 (es) 2010-03-22 2016-03-17 Cempra Pharmaceuticals, Inc. Formas cristalinas de un macrólido, y usos de las mismas
ES2636948T3 (es) 2010-05-20 2017-10-10 Cempra Pharmaceuticals, Inc. Procesos para preparar macrólidos y cetólidos e intermediarios para los mismos
WO2012034058A1 (en) 2010-09-10 2012-03-15 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
IN2014DN08939A (xx) 2012-03-27 2015-05-22 Cempra Pharmaceuticals Inc
CN105163785A (zh) 2013-03-14 2015-12-16 森普拉制药公司 用于治疗呼吸道疾病的方法及其制剂
RU2015138797A (ru) 2013-03-15 2017-04-24 Семпра Фармасьютикалс, Инк. Конвергентные способы получения макролидных антибактериальных агентов

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
NO996108L (no) 2000-02-10
NO996108D0 (no) 1999-12-10
EA199901016A1 (ru) 2000-06-26
BR9810021A (pt) 2000-09-19
OA11225A (en) 2003-07-17
HUP0002252A2 (hu) 2000-12-28
PL337606A1 (en) 2000-08-28
ID24529A (id) 2000-07-20
GT199800074A (es) 1999-11-27
WO1998056800A1 (en) 1998-12-17
CZ9904388A3 (cs) 2002-10-16
TNSN98083A1 (fr) 2005-03-15
IS5251A (is) 1999-11-16
PA8451801A1 (es) 2000-05-24
TR199902995T2 (xx) 2000-02-21
KR20010013660A (ko) 2001-02-26
MA26505A1 (fr) 2004-12-20
CO4940506A1 (es) 2000-07-24
PE79899A1 (es) 1999-08-25
HUP0002252A3 (en) 2002-01-28
ZA985018B (en) 1999-12-10
AU7226798A (en) 1998-12-30
HRP980316A2 (en) 1999-04-30
CA2293335A1 (en) 1998-12-17
HN1998000073A (es) 1999-01-08
AR012244A1 (es) 2000-09-27
AP9801253A0 (en) 1999-12-04
JP2000513026A (ja) 2000-10-03
CN1259135A (zh) 2000-07-05
EP0988308A1 (en) 2000-03-29
IL132767A0 (en) 2001-03-19
TW448174B (en) 2001-08-01

Similar Documents

Publication Publication Date Title
BG103947A (en) Derivatives of 9-oxymerythromycin
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
BG103417A (en) Condensed pyrimidine bicyclic derivatives
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
MY115662A (en) Novel compounds with analgesic effect
BG103969A (en) C-4"-substituted macrolide derivatives
AP9701019A0 (en) Phenylamino-substituted tricycle derivatives.
BG103518A (en) 2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives
PA8486401A1 (es) Antibioticos cetolidos carbamato y carbazato
MY122353A (en) 13-membered azalides and their use as antibiotic agents
MY115211A (en) Novel amino acid derivatives, their preparation and use
CA2286511A1 (en) Novel macrolide derivatives
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
AP9801377A0 (en) Tricyclic erythromycin derivatives.
IL110460A0 (en) Bis-naphthalimides and pharmaceutical compositions containing them
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
TW252979B (xx)
AU2566101A (en) Compounds and methods for the treatment of pain
WO2001005386A3 (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
YU46302A (sh) Supstituisani piroli
AP9801235A0 (en) Erythromycin derivatives.
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
AP2002002494A0 (en) Hygromycin derivatives.
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use
MXPA99003849A (es) Derivados 9a, 11b-deshidro de 9-oxima-3-ceto-6-0-metileritromicina.